Education
About Us
Working with TipRanks
Follow Us
Vioquest Pharmaceuticals Inc (VOQP)
OTHER OTC:VOQP
VOQP Stock Chart & Stats
Day’s Range― - ―
52-Week Range$0.01 - $0.01
Previous CloseN/A
Volume24.00
Average Volume (3M)0.00
Market Cap
N/A
Enterprise ValueN/A
Total Cash (Recent Filing)N/A
Total Debt (Recent Filing)N/A
Price to Earnings (P/E)―
Beta-0.54
Next EarningsN/A
EPS EstimateN/A
Next Dividend Ex-DateN/A
Dividend YieldN/A
Share Statistics
EPS (TTM)N/A
Shares Outstanding5,462,000
10 Day Avg. Volume0
30 Day Avg. Volume0
Financial Highlights & Ratios
PEG RatioN/A
Price to Book (P/B)N/A
Price to Sales (P/S)0.00
P/FCF RatioN/A
Enterprise Value/Market CapN/A
Enterprise Value/RevenueN/A
Enterprise Value/Gross ProfitN/A
Enterprise Value/EbitdaN/A
Forecast
1Y Price TargetN/A
Price Target UpsideN/A
Rating ConsensusN/A
Number of Analyst Covering0
Options Prices
Currently, No data available
---
Ownership Overview
―
Insiders
<0.01% Other Institutional Investors
100.00% Public Companies and
Individual Investors
VOQP FAQ
What was Vioquest Pharmaceuticals Inc’s price range in the past 12 months?
Vioquest Pharmaceuticals Inc lowest stock price was $0.01 and its highest was $0.01 in the past 12 months.
What is Vioquest Pharmaceuticals Inc’s market cap?
Currently, no data Available
When is Vioquest Pharmaceuticals Inc’s upcoming earnings report date?
The company’s upcoming earnings report date is not yet available.
How were Vioquest Pharmaceuticals Inc’s earnings last quarter?
Currently, no data Available
Is Vioquest Pharmaceuticals Inc overvalued?
According to Wall Street analysts Vioquest Pharmaceuticals Inc’s price is currently Overvalued.
Does Vioquest Pharmaceuticals Inc pay dividends?
Vioquest Pharmaceuticals Inc does not currently pay dividends.
What is Vioquest Pharmaceuticals Inc’s EPS estimate?
Vioquest Pharmaceuticals Inc’s EPS estimate for its next earnings report is not yet available.
How many shares outstanding does Vioquest Pharmaceuticals Inc have?
Vioquest Pharmaceuticals Inc has 5,462,000 shares outstanding.
What happened to Vioquest Pharmaceuticals Inc’s price movement after its last earnings report?
Currently, no data Available
Which hedge fund is a major shareholder of Vioquest Pharmaceuticals Inc?
Currently, no hedge funds are holding shares in VOQP
Company Description
Vioquest Pharmaceuticals Inc
VioQuest Pharmaceuticals, Inc., a biopharmaceutical company, focuses on the acquisition, development, and commercialization of clinical stage drug therapies for the treatment of oncology and infectious diseases. Its lead product includes Xyfid, which is under development for the treatment and prevention of hand-foot syndrome. The company's products also consist of VQD-002, a nucleoside analog that is in Phase I clinical trials for the treatment of cancer; and Lenocta, a small molecule inhibitor of various protein tyrosine phosphatases, which is in Phase IIa clinical trials for the treatment of melanoma, renal cell carcinoma, and other solid tumors. VioQuest Pharmaceuticals also provides chiral products, technology, and custom synthesis development services to pharmaceutical and fine chemical companies in various stages of a products' lifecycle. The company was founded in 2000 and is headquartered in Basking Ridge, New Jersey.
Technical Analysis
Biodexa Pharmaceuticals
―
Salarius Pharmaceuticals
―
Hepion Pharmaceuticals
―
Windtree Therapeutics
―
Virpax Pharmaceuticals
―